Correlation Between Item 9 and Pmv Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Item 9 and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Item 9 and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Item 9 Labs and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Item 9 and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Item 9 with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Item 9 and Pmv Pharmaceuticals.

Diversification Opportunities for Item 9 and Pmv Pharmaceuticals

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Item and Pmv is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Item 9 Labs and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Item 9 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Item 9 Labs are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Item 9 i.e., Item 9 and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Item 9 and Pmv Pharmaceuticals

Given the investment horizon of 90 days Item 9 Labs is expected to generate 29.66 times more return on investment than Pmv Pharmaceuticals. However, Item 9 is 29.66 times more volatile than Pmv Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  1.70  in Item 9 Labs on September 12, 2024 and sell it today you would lose (1.69) from holding Item 9 Labs or give up 99.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.4%
ValuesDaily Returns

Item 9 Labs  vs.  Pmv Pharmaceuticals

 Performance 
       Timeline  
Item 9 Labs 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Item 9 Labs are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile essential indicators, Item 9 sustained solid returns over the last few months and may actually be approaching a breakup point.
Pmv Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Item 9 and Pmv Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Item 9 and Pmv Pharmaceuticals

The main advantage of trading using opposite Item 9 and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Item 9 position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.
The idea behind Item 9 Labs and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios